bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.08.08.552504

Investigating the impact of motion in the scanner on brain age predictions

Abstract

IntroductionBrain Age Gap (BAG) is defined as the difference between the brains predicted age and the chronological age of an individual. Magnetic resonance imaging (MRI)-based BAG can quantify acceleration of brain aging, and is used to infer brain health as aging and disease interact. Motion in the scanner is a common occurrence that can affect the acquired MRI data and act as a major confound in the derived models. As such, age-related changes in head motion may impact the observed age-related differences. However, the relationship between head motion and BAG as estimated by structural MRI has not been systematically examined. The aim of this study is to assess the impact of motion on voxel-based morphometry (VBM) based BAG. MethodsData were obtained from two sources: i) T1-weighted (T1w) MRIs from the Cambridge Centre for Ageing and Neuroscience (CamCAN) were used to train the brain age prediction model, and ii) T1w MRIs from the Movement-related artifacts (MR-ART) dataset were used to assess the impact of motion on BAG. MR-ART includes one motion-free and two motion-affected (one low and one high) 3D T1w MRIs. We also visually rated the motion levels of the MR-ART MRIs from 0 to 5, with 0 meaning no motion and 5 high motion levels. All images were pre-processed through a standard VBM pipeline. GM density across cortical and subcortical regions were then used to train the brain age prediction model and assess the relationship between BAG and MRI motion. Principal component analysis was used to perform dimension reduction and extract the VBM-based features. BAG was estimated by regressing out the portion of delta age explained by chronological age. Linear mixed effects models were used to investigate the relationship between BAG and motion session as well as motion severity, including participant IDs as random effects. We repeated the same analysis using cortical thickness based on FreeSurfer 7.4.1 and to compare the results for volumetric versus surface-based measures of brain morphometry. ResultsIn contrast with the session with no induced motion, predicted delta age was significantly higher for high motion sessions 2.35 years (t = 5.17, p < 0.0001), with marginal effect for low motion sessions 0.95 years (t = 2.11, p=0.035) for VBM analysis as well as 3.46 years (t = 11.45, p < 0.0001) for high motion and 2.28 years (t = 7.54, p<0.0001) for low motion based on cortical thickness. In addition, delta age was significantly associated with motion severity as evaluated by visual rating 0.45 years per rating level (t = 4.59, p < 0.0001) for VBM analysis and 0.83 years per motion level (t = 12.89, p<0.0001) for cortical thickness analysis. ConclusionMotion in the scanner can significantly impact brain age estimates, and needs to be accounted for as a confound, particularly when studying populations that are known to have higher levels of motion in the scanner. These results have significant implications for brain age studies in aging and neurodegeneration. Based on these findings, we recommend assessment and inclusion of visual motion ratings in such studies. In cases that the visual rating proves prohibitive, we recommend the inclusion of normalized Euler number from FreeSurfer as defined in the manuscript as a covariate in the models.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Moqadam, R., Dadar, M., Zeighami, Y.. 2023-08-13. Investigating the impact of motion in the scanner on brain age predictions. https://doi.org/10.1101/2023.08.08.552504

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗